SOLVO Biotechnology owns a substantial patent portfolio relating to drug targets and modulators, gene therapy applications and functional aspects of pharmacogenetics. All major pharma and biotech companies use SOLVO’s assays, either in-house, or as contract research.
Our Calcein Assay® is protected by 14 patents worldwide. At the same time SOLVO’s patent portfolio includes 7 pending patent applications relating to new ABC transporter technologies with special regards to simple quantitative fluorescent assay methods, novel cholesterol loaded cell membrane preparations, and procedure and reagent kit for in vitro malaria diagnostic purposes.
SOLVO Biotechnology regularly acquires relevant licenses of transporter technologies resulting from basic research conducted at different universities and research institutions worldwide.